Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Gastric Emptying Study Will Be Required in Ozempic Gastroparesis Lawsuits: MDL Order Court indicates most cases will survive the ruling, as many plaintiffs suffer long-term stomach paralysis from Ozempic or other GLP-1s, and can still be tested. August 20, 2025 Irvin Jackson Add Your Comments The U.S. District Judge presiding over all federal Ozempic lawsuits, Wegovy lawsuits, Mounjaro lawsuits and other claims involving side effects of GLP-1 medications has issued a critical ruling clearing the litigation to move forward, as long as plaintiffs diagnosed with gastroparesis are able to provide evidence of a gastric emptying study to support their diagnosis. Novo Nordisk and Eli Lilly face more than 2,400 product liability lawsuits brought throughout the federal court system over the past few years, each indicating that the manufacturers failed to provide adequate warning that the diabetes and weight loss drugs could cause severe gastrointestinal problems, including gastroparesis, bowel obstructions and other painful side effects. The medications at issue in the litigation all belong to a popular new class of drugs, known as glucagon-like peptide-1 (GLP-1) receptor agonists, which also includes Victoza, Rybelsus and Trulicity. While the drugs were originally developed to treat type 2 diabetes, use of the treatments has exploded in popularity over the past few years, due to their weight loss benefits. However, a growing number of users are now filing lawsuits against the drug makers, alleging that they withheld critical safety information and warnings, particularly about the risk that users may be left with devastating stomach paralysis injuries. Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION Given common questions of fact and law raised in complaints filed in U.S. District Courts nationwide, all Ozempic gastroparesis lawsuits have been centralized into a multidistrict litigation (MDL) in the Eastern District of Pennsylvania, where U.S. District Judge Karen Marston is overseeing pretrial proceedings, coordinated discovery, and plan to prepare a group of representative claims to serve as early test “bellwether” trials. These trials will allow both sides and the court to see how juries will respond to evidence and testimony likely to be repeated throughout the litigation. However, before scheduling those bellwether trials, Judge Marston required the parties to address certain “cross-cutting” issues, which would have widespread implications on the litigation. Early in the litigation, the parties were directed to prioritize discovery and motions on three key issues, including whether claims are preempted by federal law, whether plaintiffs are required to present specific diagnostic testing evidence and whether there is sufficient general causation evidence linking Ozempic and the gastrointestinal injuries. Ozempic Lawsuits Require Gastric Study Judge Marston decided the issue of diagnostic testing in a court order (PDF) issued on August 15, indicating all plaintiffs pursuing a gastroparesis lawsuit against the makers of Ozempic or other GLP-1 medications must have their gastroparesis verified through a gastric emptying study. Plaintiffs had argued that there were additional ways to diagnose stomach paralysis, and that the requirement was too restrictive, as many doctors probably diagnosed the condition without requiring one of those methods. However, in an accompanying memorandum (PDF) explaining her decision, the judge said she did not believe the ruling would have a large effect on the litigation, as most of the injuries reported are persistent gastroparesis, which could still be diagnosed through a scintigraphy, breath test, or wireless motility capsule (WMC). Therefore, she has granted plaintiffs leave to file amended complaints once they have undergone the proper testing. “[T]he Court recognizes that given this ruling, some Plaintiffs in this MDL will be unable to prove that they suffered from gastroparesis because their diagnosis was not based on a properly performed gastric emptying study. Although unfortunate, it would be perhaps more unjust to hold Defendants potentially liable for damages based on an unreliable diagnosis.” — U.S. District Judge Karen Marston Once the other cross-cutting issues have been resolved, the Court is expected to move forward in scheduling those early bellwether trials. While the outcomes of those early test trials will not be binding on other GLP-1 lawsuits, they will be closely watched and may help the parties negotiate Ozempic gastroparesis settlements to resolve a large number of claims in the future. If the cases have not been resolved following the bellwether trials, Judge Marston would then likely remand the claims back to their courts of origin in preparation for individual trial dates. Find Out If You Qualify for Ozempic or Wegovy Compensation Tags: Diabetes, Diabetes Drugs, Eli Lilly, Gastroparesis, Mounjaro, Novo Nordisk, Ozempic, Stomach Paralysis, Weight Loss Written By: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. More Ozempic, Wegovy and Mounjaro Stories Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues October 28, 2025 Ozempic Gastroparesis Problems Persisted After Injections Stopped, Lawsuit Alleges October 21, 2025 Ozempic, Wegovy Kidney Side Effects Highlighted in New Study October 10, 2025 0 Comments URLThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Dupixent Sales Surge Amid Growing CTCL Cancer Lawsuit Allegations (Posted: today) Sanofi indicates Dupixent sales are growing stronger as the medication gathers more indications for use worldwide, despite recent cancer concerns. MORE ABOUT: DUPIXENT LAWSUITDupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit (10/17/2025)Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (10/08/2025)Dupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025) Studies Highlight How Sports Betting Apps Cause Compulsive Gambling Addiction (Posted: yesterday) Researchers warn that sports-betting apps use reward-based design and constant engagement tactics that can fuel addiction among young adults—sparking a surge of lawsuits accusing major platforms of exploiting these vulnerabilities for profit. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITGambling Addiction Treatment Needs Surge Amid Sports Betting App Promotions (10/22/2025)Gambling Livestreams May Be Harming Young Adults: Study (10/16/2025)DraftKings Faces Lawsuit Over Failure To Design Sports Betting Website for Gamblers Disabilities (09/29/2025) Internal Bra Side Effects Raise Questions About Manufacturers’ Knowledge of Mesh Failures (Posted: 2 days ago) Breast mesh products marketed as “internal bras” for lift and augmentation surgeries are now under investigation amid reports of painful complications, and questions over manufacturers’ prior knowledge of mesh-related risks. MORE ABOUT: BREAST MESH LAWSUITBreast Mesh Problems Prompted FDA Warnings Over Off-Label Use (10/15/2025)Breast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (10/09/2025)FDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023)
Dupixent Sales Surge Amid Growing CTCL Cancer Lawsuit Allegations (Posted: today) Sanofi indicates Dupixent sales are growing stronger as the medication gathers more indications for use worldwide, despite recent cancer concerns. MORE ABOUT: DUPIXENT LAWSUITDupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit (10/17/2025)Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (10/08/2025)Dupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)
Studies Highlight How Sports Betting Apps Cause Compulsive Gambling Addiction (Posted: yesterday) Researchers warn that sports-betting apps use reward-based design and constant engagement tactics that can fuel addiction among young adults—sparking a surge of lawsuits accusing major platforms of exploiting these vulnerabilities for profit. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITGambling Addiction Treatment Needs Surge Amid Sports Betting App Promotions (10/22/2025)Gambling Livestreams May Be Harming Young Adults: Study (10/16/2025)DraftKings Faces Lawsuit Over Failure To Design Sports Betting Website for Gamblers Disabilities (09/29/2025)
Internal Bra Side Effects Raise Questions About Manufacturers’ Knowledge of Mesh Failures (Posted: 2 days ago) Breast mesh products marketed as “internal bras” for lift and augmentation surgeries are now under investigation amid reports of painful complications, and questions over manufacturers’ prior knowledge of mesh-related risks. MORE ABOUT: BREAST MESH LAWSUITBreast Mesh Problems Prompted FDA Warnings Over Off-Label Use (10/15/2025)Breast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (10/09/2025)FDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023)